Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)

Clinical trial NCT02796651 · COMPLETED

Trial details

NCT number: NCT02796651
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease - COPD

Start date: 2016-06-30
Primary completion: 2016-12-07
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.